Target intelligence / Profile preview

C17orf58 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

The C17orf58 pseudogene (ENSG00000261575) is classified as a pseudogene, meaning it is a genetic sequence with high similarity to a protein-coding gene but is not capable of encoding a functional protein product[1][3][4]. Pseudogenes can arise through duplication or retrotransposition but lack the necessary regulatory elements, intact open reading frames, or accumulated disabling mutations such as frameshifts or premature stop codons, hence do not produce proteins[3][5]. Most pseudogenes, including the C17orf58 pseudogene, do not have established biological functions or roles in disease, and they are not considered therapeutic targets such as receptors, enzymes, or transporters[1][3][5]. Some pseudogenes in general can have regulatory roles via noncoding RNA mechanisms or as microRNA decoys in select cases, but there is no evidence suggesting such a role for C17orf58 pseudogene[5]. Additional notes: - The C17orf58 gene (not the pseudogene) is a protein-coding gene and should not be confused with the pseudogene[2]. - This entry is marked as **not a therapeutic target** and should not be used as such. No drugs or mechanisms of action are associated with this pseudogene. - The query appears to refer to a *pseudogene* that lacks direct therapeutic significance; this is a common confusion when gene lists include both functional proteins and pseudogenes.

Other names
GC17P044346GC17P046269GC17P046272GC17P046277GC17P046288GC17P046367GC17P046403GC17P046432GC17P046485GC17P046982GC17P047600GC17P048134GC17P048894GC17P050953GC17P053303GC17P055818GC17P058739GC17P062134GC17P067012GC17P072011GC17P078292GC17P086529GC17P093778GC17P101722GC17P112445GC17P123177GC17P133913GC17P144574

Beyond the preview

Go deeper on C17orf58 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C17orf58 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call